Do you know where to turn to for
your USP <797> compliance solutions?
The answer is right HERE
(Micro-Clean, Inc. On-Site USP 797 Gap Anaysis
Request).
Micro-Clean, Inc. has teamed up with Clinical IQ, LLC
and Controlled Environment Consulting, Inc. to provide our pharmaceutical
customers with a single-source for their USP <797> compliance
solutions.
The solutions consist of a comprehensive on-site
USP 797 Gap Analysis to determine areas requiring attention and
a
report describing corrective actions as well as positive feedback
on all USP <797> compliance issues such as:
- Responsibilities of all compounding personnel
- Basis for the classification of a CSP (Compounding
Sterile Preparations) into low-, medium-, or high-risk level, with
examples of CSPs and their quality assurance practices in each of
these risk levels
- Verification of compounding accuracy and sterilization
- Personnel training and evaluation in aseptic manipulation
skills, including representative sterile microbial culture medium
transfer and fill challenges
- Environmental quality and control during the processing
of Compounding Sterile Preparations
- Equipment used in the preparation of Compounding Sterile
Preparations
- Verification of automated compounding devices for parenteral
nutrition compounding
- Finished preparation release checks and tests
- Storage and beyond-use dating
- Maintaining product quality and control after CSPs
leave the compounding facility, including education and training of
personnel
- Packing, handling, storage, and transport of Compounding
Sterile Preparations
- Patient or caregiver training
- Patient monitoring and adverse events reporting
- A quality assurance program for Compounding Sterile
Preparations
This team is lead by:
Eric S. Kastango, RPh, MBA, FASHP, President, Clinical
IQ, LLC
James T. Wagner, President, Controlled Environment Consulting, Inc.
Eric Kastango has been in the forefront of USP <797>
since its inception. He is an elected member of the
United States Pharmacopoeia Sterile Compounding Committee (2005-2010).
Over the years, he has held multiple American
Society of Health-System Pharmacists chairmanships and committee
positions. He was responsible for creating the “Comprehensive
Sterile Compounding Compliance Gap Analysis and Risk Assessment Tool”
being used and marketed by the ASHP.
Jim Wagner has been an industry leader in the field of
HEPA filtration and environmental control for over 25 years. He is an
elected member of the United States Pharmacopoeia Engineering Controls
Committee (2005-2010). He is the current president of the Controlled
Environment Testing Association , an industry organization currently
developing recommended practices for aseptic compounding facilities,
an isolator applications guide and compounding isolator testing.
Request a quotation by clicking right HERE
( Micro-Clean,Inc.
USP 797 Comprehensive On-site
Gap Analysis Request)
Micro-Clean, Inc. also hosts Pharmacist
Training in our Lehigh Valley facility:
The Aseptic
Training Program offered by Clinical IQ, LLC and Controlled
Environment Consulting in cooperation with the Contamination Control
Institute (C2I) will offer participants the unique opportunity to combine
classroom training and hands-on practice to develop and enhance their
sterile compounding skills, while learning how to integrate quality
into their daily activities. Attendees will have the opportunity to
work in a cleanroom, barrier isolators, biological safety cabinets and
laminar airflow workbenches and will undergo aseptic media fill qualification,
learn how to establish an environmental monitoring program, perform
environmental sampling, cleaning and sanitizing, designing and building
a cleanroom.